- Home
- SPXC vs JAZZ Comparison
SPXC vs JAZZ Comparison
Compare SPXC & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPXC
- JAZZ
- Stock Information
- Founded
- SPXC 1912
- JAZZ 2003
- Country
- SPXC United States
- JAZZ Ireland
- Employees
- SPXC N/A
- JAZZ N/A
- Industry
- SPXC Industrial Machinery/Components
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- SPXC Industrials
- JAZZ Health Care
- Exchange
- SPXC Nasdaq
- JAZZ Nasdaq
- Market Cap
- SPXC 9.2B
- JAZZ 7.9B
- IPO Year
- SPXC N/A
- JAZZ 2007
- Fundamental
- Price
- SPXC $187.37
- JAZZ $136.58
- Analyst Decision
- SPXC Strong Buy
- JAZZ Strong Buy
- Analyst Count
- SPXC 4
- JAZZ 14
- Target Price
- SPXC $200.25
- JAZZ $179.21
- AVG Volume (30 Days)
- SPXC 276.9K
- JAZZ 758.5K
- Earning Date
- SPXC 10-30-2025
- JAZZ 11-05-2025
- Dividend Yield
- SPXC N/A
- JAZZ N/A
- EPS Growth
- SPXC 100.86
- JAZZ N/A
- EPS
- SPXC 4.47
- JAZZ N/A
- Revenue
- SPXC $2,052,400,000.00
- JAZZ $4,086,695,000.00
- Revenue This Year
- SPXC $15.43
- JAZZ $5.70
- Revenue Next Year
- SPXC $8.03
- JAZZ $6.16
- P/E Ratio
- SPXC $42.04
- JAZZ N/A
- Revenue Growth
- SPXC 8.90
- JAZZ 4.52
- 52 Week Low
- SPXC $115.00
- JAZZ $95.49
- 52 Week High
- SPXC $209.38
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- SPXC 49.97
- JAZZ 63.56
- Support Level
- SPXC $183.49
- JAZZ $125.79
- Resistance Level
- SPXC $185.24
- JAZZ $140.39
- Average True Range (ATR)
- SPXC 4.52
- JAZZ 3.18
- MACD
- SPXC 0.25
- JAZZ 0.46
- Stochastic Oscillator
- SPXC 54.97
- JAZZ 71.59
About SPXC SPX Technologies Inc.
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.